Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain

Evidence for interactions between the kinase and pseudokinase domains

Min Chen, Alan Cheng, Fabio Candotti, Yong Jie Zhou, Anka Hymel, Anders Fasth, Luigi D. Notarangelo, John J. O'Shea

Research output: Contribution to journalArticle

Abstract

The structure of Janus kinases (JAKs) is unique among protein tyrosine kinases in having tandem, nonidentical kinase and pseudokinase domains. Despite its conservation in evolution, however, the function of the pseudokinase domain remains poorly understood. Lack of JAK3 expression results in severe combined immunodeficiency (SCID). In this study, we analyze two SCID patients with mutations in the JAK3 pseudokinase domain, which allows for protein expression but disrupts the regulation of the kinase activity. Specifically, these mutant forms of JAK3 had undetectable kinase activity in vitro but were hyperphosphorylated both in patients' Epstein-Barr virus-transformed B cells and when overexpressed in COS7 cells. Moreover, reconstitution of cells with these mutants demonstrated that, although they were constitutively phosphorylated basally, they were unable to transmit cytokine-dependent signals. Further analysis showed that the isolated catalytic domain of JAK3 was functional whereas either the addition of the pseudokinase domain or its deletion from the full-length molecule reduced catalytic activity. Through coimmunoprecipitation of the isolated pseudokinase domain with the isolated catalytic domain, we provide the first evidence that these two domains interact. Furthermore, whereas the wild-type pseudokinase domain modestly inhibited kinase domain-mediated STATS phosphorylation, the patient-derived mutants markedly inhibited this phosphorylation. We thus conclude that the JAK3 pseudokinase domain is essential for JAK3 function by regulating its catalytic activity and autophosphorylation. We propose a model in which this occurs via intramolecular interaction with the kinase domain and that increased inhibition of kinase activity by the pseudokinase domain likely contributes to the disease pathogenesis in these two patients.

Original languageEnglish (US)
Pages (from-to)947-956
Number of pages10
JournalMolecular and Cellular Biology
Volume20
Issue number3
DOIs
StatePublished - Feb 2000
Externally publishedYes

Fingerprint

Phosphotransferases
Mutation
Severe Combined Immunodeficiency
Catalytic Domain
Phosphorylation
Janus Kinases
Human Herpesvirus 4
Protein-Tyrosine Kinases
B-Lymphocytes
Cytokines
Proteins

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain : Evidence for interactions between the kinase and pseudokinase domains. / Chen, Min; Cheng, Alan; Candotti, Fabio; Zhou, Yong Jie; Hymel, Anka; Fasth, Anders; Notarangelo, Luigi D.; O'Shea, John J.

In: Molecular and Cellular Biology, Vol. 20, No. 3, 02.2000, p. 947-956.

Research output: Contribution to journalArticle

Chen, Min ; Cheng, Alan ; Candotti, Fabio ; Zhou, Yong Jie ; Hymel, Anka ; Fasth, Anders ; Notarangelo, Luigi D. ; O'Shea, John J. / Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain : Evidence for interactions between the kinase and pseudokinase domains. In: Molecular and Cellular Biology. 2000 ; Vol. 20, No. 3. pp. 947-956.
@article{0de4d870b45d4c20930d5aaf12aaff90,
title = "Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains",
abstract = "The structure of Janus kinases (JAKs) is unique among protein tyrosine kinases in having tandem, nonidentical kinase and pseudokinase domains. Despite its conservation in evolution, however, the function of the pseudokinase domain remains poorly understood. Lack of JAK3 expression results in severe combined immunodeficiency (SCID). In this study, we analyze two SCID patients with mutations in the JAK3 pseudokinase domain, which allows for protein expression but disrupts the regulation of the kinase activity. Specifically, these mutant forms of JAK3 had undetectable kinase activity in vitro but were hyperphosphorylated both in patients' Epstein-Barr virus-transformed B cells and when overexpressed in COS7 cells. Moreover, reconstitution of cells with these mutants demonstrated that, although they were constitutively phosphorylated basally, they were unable to transmit cytokine-dependent signals. Further analysis showed that the isolated catalytic domain of JAK3 was functional whereas either the addition of the pseudokinase domain or its deletion from the full-length molecule reduced catalytic activity. Through coimmunoprecipitation of the isolated pseudokinase domain with the isolated catalytic domain, we provide the first evidence that these two domains interact. Furthermore, whereas the wild-type pseudokinase domain modestly inhibited kinase domain-mediated STATS phosphorylation, the patient-derived mutants markedly inhibited this phosphorylation. We thus conclude that the JAK3 pseudokinase domain is essential for JAK3 function by regulating its catalytic activity and autophosphorylation. We propose a model in which this occurs via intramolecular interaction with the kinase domain and that increased inhibition of kinase activity by the pseudokinase domain likely contributes to the disease pathogenesis in these two patients.",
author = "Min Chen and Alan Cheng and Fabio Candotti and Zhou, {Yong Jie} and Anka Hymel and Anders Fasth and Notarangelo, {Luigi D.} and O'Shea, {John J.}",
year = "2000",
month = "2",
doi = "10.1128/MCB.20.3.947-956.2000",
language = "English (US)",
volume = "20",
pages = "947--956",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain

T2 - Evidence for interactions between the kinase and pseudokinase domains

AU - Chen, Min

AU - Cheng, Alan

AU - Candotti, Fabio

AU - Zhou, Yong Jie

AU - Hymel, Anka

AU - Fasth, Anders

AU - Notarangelo, Luigi D.

AU - O'Shea, John J.

PY - 2000/2

Y1 - 2000/2

N2 - The structure of Janus kinases (JAKs) is unique among protein tyrosine kinases in having tandem, nonidentical kinase and pseudokinase domains. Despite its conservation in evolution, however, the function of the pseudokinase domain remains poorly understood. Lack of JAK3 expression results in severe combined immunodeficiency (SCID). In this study, we analyze two SCID patients with mutations in the JAK3 pseudokinase domain, which allows for protein expression but disrupts the regulation of the kinase activity. Specifically, these mutant forms of JAK3 had undetectable kinase activity in vitro but were hyperphosphorylated both in patients' Epstein-Barr virus-transformed B cells and when overexpressed in COS7 cells. Moreover, reconstitution of cells with these mutants demonstrated that, although they were constitutively phosphorylated basally, they were unable to transmit cytokine-dependent signals. Further analysis showed that the isolated catalytic domain of JAK3 was functional whereas either the addition of the pseudokinase domain or its deletion from the full-length molecule reduced catalytic activity. Through coimmunoprecipitation of the isolated pseudokinase domain with the isolated catalytic domain, we provide the first evidence that these two domains interact. Furthermore, whereas the wild-type pseudokinase domain modestly inhibited kinase domain-mediated STATS phosphorylation, the patient-derived mutants markedly inhibited this phosphorylation. We thus conclude that the JAK3 pseudokinase domain is essential for JAK3 function by regulating its catalytic activity and autophosphorylation. We propose a model in which this occurs via intramolecular interaction with the kinase domain and that increased inhibition of kinase activity by the pseudokinase domain likely contributes to the disease pathogenesis in these two patients.

AB - The structure of Janus kinases (JAKs) is unique among protein tyrosine kinases in having tandem, nonidentical kinase and pseudokinase domains. Despite its conservation in evolution, however, the function of the pseudokinase domain remains poorly understood. Lack of JAK3 expression results in severe combined immunodeficiency (SCID). In this study, we analyze two SCID patients with mutations in the JAK3 pseudokinase domain, which allows for protein expression but disrupts the regulation of the kinase activity. Specifically, these mutant forms of JAK3 had undetectable kinase activity in vitro but were hyperphosphorylated both in patients' Epstein-Barr virus-transformed B cells and when overexpressed in COS7 cells. Moreover, reconstitution of cells with these mutants demonstrated that, although they were constitutively phosphorylated basally, they were unable to transmit cytokine-dependent signals. Further analysis showed that the isolated catalytic domain of JAK3 was functional whereas either the addition of the pseudokinase domain or its deletion from the full-length molecule reduced catalytic activity. Through coimmunoprecipitation of the isolated pseudokinase domain with the isolated catalytic domain, we provide the first evidence that these two domains interact. Furthermore, whereas the wild-type pseudokinase domain modestly inhibited kinase domain-mediated STATS phosphorylation, the patient-derived mutants markedly inhibited this phosphorylation. We thus conclude that the JAK3 pseudokinase domain is essential for JAK3 function by regulating its catalytic activity and autophosphorylation. We propose a model in which this occurs via intramolecular interaction with the kinase domain and that increased inhibition of kinase activity by the pseudokinase domain likely contributes to the disease pathogenesis in these two patients.

UR - http://www.scopus.com/inward/record.url?scp=0033965488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033965488&partnerID=8YFLogxK

U2 - 10.1128/MCB.20.3.947-956.2000

DO - 10.1128/MCB.20.3.947-956.2000

M3 - Article

VL - 20

SP - 947

EP - 956

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 3

ER -